HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nivetha Murugesan Selected Research

Plasma Kallikrein

1/2022Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema.
1/2022KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results.
1/2019Retinal proteome associated with bradykinin-induced edema.
1/2016Plasma Kallikrein Mediates Vascular Endothelial Growth Factor-Induced Retinal Dysfunction and Thickening.
10/2015Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.
9/2015Thrombosis and Hemorrhage in Diabetic Retinopathy: A Perspective from an Inflammatory Standpoint.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nivetha Murugesan Research Topics

Disease

3Macular Edema
01/2019 - 09/2015
3Edema (Dropsy)
01/2019 - 09/2015
2Hereditary Angioedemas
01/2022 - 01/2022
2Inflammation (Inflammations)
01/2016 - 09/2015
2Neuroinflammatory Diseases
08/2012 - 09/2009
1Inborn Genetic Diseases (Disease, Hereditary)
01/2022
1Pain (Aches)
01/2022
1Papilledema
01/2016
1Retinal Neovascularization
01/2016
1Retinal Perforations
10/2015
1Diabetic Retinopathy (Retinopathy, Diabetic)
09/2015
1Ischemia
09/2015
1Hemorrhage
09/2015
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
08/2012
1Endotoxemia
09/2009

Drug/Important Bio-Agent (IBA)

6Plasma KallikreinIBA
01/2022 - 09/2015
3Retinaldehyde (Retinal)IBA
01/2019 - 09/2015
2BradykininIBA
01/2022 - 01/2019
2sebetralstatIBA
01/2022 - 01/2022
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 10/2015
1Hormones (Hormone)IBA
01/2022
1High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA
01/2022
1ProteomeIBA
01/2019
1Oxygen (Dioxygen)IBA
01/2016
1Serine Proteases (Serine Protease)IBA
01/2016
1PrekallikreinIBA
10/2015
1KininsIBA
10/2015
1ThrombinFDA Link
09/2015
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
09/2015
1Blood Coagulation Factors (Coagulation Factor)IBA
09/2015
1Myelin-Oligodendrocyte GlycoproteinIBA
08/2012
1Peptides (Polypeptides)IBA
08/2012
1Pharmaceutical PreparationsIBA
09/2009
1LipopolysaccharidesIBA
09/2009

Therapy/Procedure

1Lasers (Laser)
09/2009
1Therapeutics
09/2009